Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Intangibles (2023 - 2026)

Perspective Therapeutics' Intangibles history spans 8 years, with the latest figure at $40.0 million for Q1 2026.

  • On a quarterly basis, Intangibles fell 20.0% to $40.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $40.0 million, a 20.0% decrease, with the full-year FY2025 number at $40.0 million, down 20.0% from a year prior.
  • Intangibles hit $40.0 million in Q1 2026 for Perspective Therapeutics, roughly flat from $40.0 million in the prior quarter.
  • Over the last five years, Intangibles for CATX hit a ceiling of $50.0 million in Q1 2023 and a floor of $40.0 million in Q4 2025.
  • Historically, Intangibles has averaged $48.5 million across 4 years, with a median of $50.0 million in 2023.
  • Biggest five-year swings in Intangibles: changed 0.0% in 2024 and later dropped 20.0% in 2025.
  • Tracing CATX's Intangibles over 4 years: stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then decreased by 20.0% to $40.0 million in 2025, then changed by 0.0% to $40.0 million in 2026.
  • Business Quant data shows Intangibles for CATX at $40.0 million in Q1 2026, $40.0 million in Q4 2025, and $50.0 million in Q3 2025.